SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits.

$PAW is trending as the community highlights its focus on sustainable growth and enterprise-level solutions, positioning it as a key Layer 1 infrastructure provider. Discussions revolve around its potential to bridge Web2 and Web3, offering simplicity, speed, and privacy for businesses.  Enthusiasm builds as partnerships are teased and enterprise integrations are anticipated.

Memecoin on Injective taken over by the community.

Nonja

$NONJA is gaining traction within its community, driven by discussions around its strong community, high burned liquidity, and successful NFT collections. Many believe it's a leveraged play on Injective ($INJ), with some anticipating substantial gains as the Injective ecosystem expands. The community emphasizes its potential as a leading meme coin on the Injective blockchain.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation of a potential acquisition offer from Saudi Arabia's Public Investment Fund (PIF), valued at over $70 billion, fueling excitement among investors. Community members are debating the deal's likelihood and fair valuation, with some wary of "fake news" and others anticipating a bidding war, while keeping a close eye on potential offers from other media giants.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

Starknet ($STRK) is trending due to growing excitement around its BTCFi integration and recent tech upgrades that slash gas costs and speed up transaction times. The community is actively discussing milestones like securing 1,000+ BTC on-chain and the potential for Starknet to scale Bitcoin and Ethereum, drawing comparisons to Zcash's privacy technology.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

BBBY is trending as the company announced a dividend of warrants to shareholders, sparking discussions around potential implications and comparisons to similar moves by other meme stocks. The community is weighing the potential for a squeeze, the impact of dilution, and the leadership's strategy. Some traders are closely monitoring technical indicators and potential trading opportunities amid volatile price swings.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors weigh several factors: a potential shift in focus from new orders to fixing relationships, news about the 777x certification at the Dubai Airshow, and the end of a union strike. Community discussions revolve around production stability and the market's reaction to Boeing's strategic shift amidst the ongoing strike resolution.

Ethereum Classic

Ethereum Classic is trending as the community discusses its potential and compares it to other cryptocurrencies like Ethereum and Bitcoin. Some traders are expressing frustration with its performance compared to other cryptos, while others remain optimistic about its future potential and are accumulating the token. The coin's price movements and potential for a breakout are key talking points.

Pony.ai, Inc. develops artificial intelligence-based robot designed for autonomous driving. The firm's software algorithms and infrastructure enables a vehicle to perceive its surroundings, predict what others will do, and maneuver itself accordingly. The company was founded by Jun Peng and Tian Cheng Lou in November 4, 2016 and is headquartered in Guangzhou, China.

Pony AI Inc. - ADR

Pony AI Inc

Pony AI Inc is trending due to a Buy rating from Bank of America and a price target upgrade, signaling confidence in its autonomous driving technology. Community discussions revolve around the company's potential for growth in the robotaxi market and expansion into new regions like Shanghai after receiving a new permit. Some investors are comparing PONY to competitors like WeRide (WRD) and weighing the company's profitability and market position against its valuation.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as Bitcoin's price fluctuations spark debate about the company's leveraged Bitcoin strategy, with community members weighing the risks and potential rewards of MSTR versus direct BTC ownership; some are pointing to technical indicators, while others are highlighting Michael Saylor's continued bullish stance and recent purchases. Concerns remain around debt levels and the impact of a potential Bitcoin bear market on MSTR's valuation.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Cel-Sci Corp

Cel-Sci ($CVM) is trending amid discussions about a potential Breakthrough Medicine Designation in Saudi Arabia for its cancer drug Multikine, with investors eagerly awaiting news. Community members are debating the likelihood of approval, the timeline for a decision, and the potential impact on the company's finances and future trials. The stock is further fueled by commentary around Ergomed being paid in shares for upcoming trials.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Amneal Pharmaceuticals (NASDAQ:AMRX) EVP Sells 131,856 Shares of Stock

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) EVP Nikita Shah sold 131,856 shares of the business's stock in a transaction that occurred on Wednesday, November 12th. The stock was sold...

Amneal Pharmaceuticals (NASDAQ:AMRX) EVP Sells $1,571,723.52 in Stock

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) EVP Nikita Shah sold 131,856 shares of the company's stock in a transaction on Wednesday, November 12th. The shares were sold at an...

ANI Pharmaceuticals Stock Surges 53% YTD: Time to Buy or Sell?

ANIP's 53% YTD surge fuels strong 2025 financial performance, a raised outlook and powerful momentum in its rare disease portfolio.

FDA Approves Amneal's Generic Version Of GE's Omnipaque; Launch Expected In Q1 2026

(RTTNews) - Amneal Pharmaceuticals Inc. (AMRX) announced that the U.S. Food and Drug Administration has approved its iohexol injection (300 mg Iodine/mL), marking the first generic version of GE...

Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 12-Month High - Should You Buy?

Amneal Pharmaceuticals (NASDAQ:AMRX) Sets New 12-Month High - Still a Buy...

Los Angeles Capital Management LLC Has $1.61 Million Stock Holdings in Amneal Pharmaceuticals, Inc. $AMRX

Los Angeles Capital Management LLC grew its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 238.0% during the 2nd quarter, according to its most recent 13F filing with...

Implied Volatility Surging for Amneal Pharmaceuticals Stock Options

Investors need to pay close attention to AMRX stock based on the movements in the options market lately. 

Amneal (AMRX) Reports Q3 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Amneal (AMRX) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Amneal Pharmaceuticals (AMRX) Beats Q3 Earnings and Revenue Estimates

Amneal (AMRX) delivered earnings and revenue surprises of +30.77% and +1.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Neurocrine Biosciences (NBIX) Q3 Earnings and Revenues Top Estimates

Neurocrine (NBIX) delivered earnings and revenue surprises of +29.11% and +6.73%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AMRX News

AMRXAmneal Pharmaceuticals Inc - Ordinary Shares - Class A